Skip Navigation
ChemIDplus A TOXNET DATABASE LiteBrowseAdvanced

Substance Name: ZMAPP
RN: 1653957-71-1


  • A mixture of c13C6, c2G4, and c4G7 monoclonal antibodies for treatment of Ebola virus infection.

    CDC: ZMapp, being developed by Mapp Biopharmaceutical Inc., is an experimental treatment, for use with individuals infected with Ebola virus. It has not yet been tested in humans for safety or effectiveness. The product is a combination of three different monoclonal antibodies that bind to the protein of the Ebola virus.

Molecular Formula

  • Unspecified
* denotes mobile formatted website

Links to Resources

Names and Synonyms


  • Ebola treatment Zmapp

Systematic Name


Registry Numbers

CAS Registry Number

  • 1653957-71-1

System Generated Number

  • 1653957711